Cargando…
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth
We aimed to identify novel molecular mechanisms for muscle growth during administration of anabolic agents. Growing pigs (Duroc/(Landrace/Large-White)) were administered Ractopamine (a beta-adrenergic agonist; BA; 20 ppm in feed) or Reporcin (recombinant growth hormone; GH; 10 mg/48 hours injected)...
Autores principales: | Brown, D. M., Williams, H., Ryan, K. J. P., Wilson, T. L., Daniel, Z. C. T. R., Mareko, M. H. D., Emes, R. D., Harris, D. W., Jones, S., Wattis, J. A. D., Dryden, I. L., Hodgman, T. C., Brameld, J. M., Parr, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923900/ https://www.ncbi.nlm.nih.gov/pubmed/27350173 http://dx.doi.org/10.1038/srep28693 |
Ejemplares similares
-
The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells
por: Brearley, Madelaine C., et al.
Publicado: (2020) -
Induction of Phosphoenolpyruvate Carboxykinase (PEPCK) during Acute Acidosis and Its Role in Acid Secretion by V-ATPase-Expressing Ionocytes
por: Furukawa, Fumiya, et al.
Publicado: (2015) -
Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy
por: Yu, Yong, et al.
Publicado: (2023) -
Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism
por: Gonzalez-Rellan, María J., et al.
Publicado: (2023) -
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors
por: Chu, Pei-Yi, et al.
Publicado: (2017)